161.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase...
by Seiwert, Tanguy Y, Dr
The lancet oncology, 2016, Vol.17 (7), p.956-965
162.
Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial
by Pickles, Andrew, Prof
The Lancet (British edition), 2016, Vol.388 (10059), p.2501-2509
163.
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
by Renehan, Andrew G, Prof
The lancet oncology, 2016, Vol.17 (2), p.174-183
164.
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
by Antonia, Scott J, Prof
The lancet oncology, 2016, Vol.17 (7), p.883-895
165.
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
by Hellmann, Matthew D, Dr
The lancet oncology, 2016, Vol.18 (1), p.31-41
166.
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
by Mahajan, Anita
The lancet oncology, 2017, Vol.18 (8), p.1040-1048
167.
Preventing Alcohol Use Among Late Adolescent Urban Youth: 6-Year Results From a Computer-Based Intervention
by SCHWINN, Traci M
Journal of studies on alcohol and drugs, 2010, Vol.71 (4), p.535-538
168.
Musculoskeletal disorders of the neck and shoulders in female sewing machine operators: prevalence, incidence, and prognosis
by Kaergaard, Anette
Occupational and environmental medicine (London, England), 2000, Vol.57 (8), p.528-534
169.
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
by Muro, Kei, Dr
The lancet oncology, 2016, Vol.17 (6), p.717-726
170.
Seasonal coronavirus protective immunity is short-lasting
by Eidge, Arthur W. D
Nature medicine, 2020, Vol.26 (11), p.1691-1693
171.
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
by Rubin, Katrine Hass
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (10), p.3848-3857
172.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
by Gæde, Peter
Diabetologia, 2016, Vol.59 (11), p.2298-2307
173.
Long-term monitoring of artificial vagina reconstructed with sigmoid colon
by Hou, X
Chinese medical journal, 2000, Vol.113 (6), p.544-546
174.
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
by Serruys, Patrick W, Prof
The Lancet (British edition), 2009, Vol.373 (9667), p.897-910
175.
Solid malignomas after bone marrow transplantation
by Latz, D
Strahlentherapie und Onkologie, 1997, Vol.173 (10), p.530-531
176.
Methadone Maintenance Treatment Experience in Macao - Prospective Follow-up for Initial 4.5 Years
by Adelson, Miriam
Journal of psychoactive drugs, 2013, Vol.45 (4), p.313-321
177.
Preoperative radiochemotherapy of esophageal carcinoma: a blessing or a curse?
by Fietkau, R
Strahlentherapie und Onkologie, 1998, Vol.174 (11), p.598-599
178.
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
by D'Amico, G.
Alimentary pharmacology & therapeutics, 2014, Vol.39 (10), p.1180-1193
179.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
by Choueiri, Toni K, Dr
The lancet oncology, 2016, Vol.17 (7), p.917-927
180.
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
by Raaschou-Nielsen, Ole, Dr
The lancet oncology, 2013, Vol.14 (9), p.813-822
